GMEDのチャート
GMEDの企業情報
| symbol | GMED |
|---|---|
| 会社名 | Globus Medical Inc （GMED グロ―バス・メディカル） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 グロバス・メディカル(Globus Medical Inc.)は医療機器会社である。同社は筋骨格系障害患者向け製品を開発する。同社は脊椎疾患患者の治療を中心とする。同社の製品は革新的融合技術と破壊的技術を含む。革新的融合技術製品には脊椎全体の脊髄障害を治療するための融合製品が含まれ、外科的アプローチで使用できる。破壊的技術製品は外科的処置と脊髄障害の治療を可能にすることによって、脊髄障害の治療における変化を表す。QUARTEXは、Occipito-Cervico-Thoracic（OCT）安定化システムである。QUARTEXは低トルクを可能にするネジロックキャップを有する。同社のパイプライン・ディスラプティブ・テクノロジー製品ポートフォリオには最小侵襲外科（MIS）技術を可能にする製品が含まれる。 グロ―バス・メディカルは米国の医療機器メ―カ―。脊椎疾患治療を中心に製品を開発、製造、販売する。同社の製品は革新的融合技術製品と破壊的技術製品の2分野に分類され、製品には脊椎固定機器｢カリバ―｣、頚椎固定用プレ―ト｢アシュア｣、椎弓形成術用器具｢キャノピ―｣などがある。 Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA. |
| 本社所在地 | 610 930-1800 |
| 代表者氏名 | David C. Paul |
| 代表者役職名 | Executive Chairman of the Board |
| 電話番号 | +1 610-930-1800 |
| 設立年月日 | 37681 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 1800人 |
| url | www.globusmedical.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 218.51200 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 4874.46700 |
| 売上高 | 売上高（百万ドル） 712.96900 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 4534.78300 |
| 当期純利益 | 当期純利益（百万ドル） 156.47300 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Globus Medical Inc revenues increased 12% to $713M. Net income before extraordinary items increased 32% to $156.5M. Revenues reflect United States segment increase of 12% to $593.9M International segment increase of 12% to $119.1M. Net income benefited from Interest income net increase from $6.6M to $13.3M (income) Other income/(loss) increase from $571K to $5.6M (income). |
GMEDのテクニカル分析
GMEDのニュース
Global Spinal Fusion Market 2015-2030: Key Trends, Regional & Competitive Insights, COVID-19 Impact - ResearchAndMarkets.com 2020/08/12 16:30:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Spinal Fusion market for the year 2020 and beyond. Companies Mentioned Medtronic plc NuVasive Inc. DePuy Synthes Inc. Globus Medical Inc. Stryker Corp. Zimmer Biomet Holdings Inc. Lumbar fusions are the most common spinal fusion procedures
Worldwide Interventional Spine Devices Market (2020 to 2024) - Featuring Alphatec Holdings, Globus Medical & Integra LifeSciences Among Others - ResearchAndMarkets.com 2020/08/05 15:52:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Interventional Spine Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The interventional spine devices market is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. The report on the interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The r
Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call 2020/07/21 20:15:00 GlobeNewswire
AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…
Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Call Transcript | AlphaStreet 2020/06/26 14:12:51 News Alphastreet
Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Conference Call Final Transcript
COVID-19: Significant Shift in Strategy of Orthopedic Implants Market 2020-2024 | Rising Prevalence of Orthopedic Conditions to Augment Growth | Technavio 2020/06/25 23:50:00 Benzinga Feeds
Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005787/en/ Technavio has announced its latest market research report titled Global Orthopedic Implants Market 2020-2024 (Graphic: Business Wire). Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
Global Spinal Fusion Market 2015-2030: Key Trends, Regional & Competitive Insights, COVID-19 Impact - ResearchAndMarkets.com 2020/08/12 16:30:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Spinal Fusion market for the year 2020 and beyond. Companies Mentioned Medtronic plc NuVasive Inc. DePuy Synthes Inc. Globus Medical Inc. Stryker Corp. Zimmer Biomet Holdings Inc. Lumbar fusions are the most common spinal fusion procedures
Worldwide Interventional Spine Devices Market (2020 to 2024) - Featuring Alphatec Holdings, Globus Medical & Integra LifeSciences Among Others - ResearchAndMarkets.com 2020/08/05 15:52:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Interventional Spine Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The interventional spine devices market is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. The report on the interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The r
Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call 2020/07/21 20:15:00 GlobeNewswire
AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…
Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Call Transcript | AlphaStreet 2020/06/26 14:12:51 News Alphastreet
Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Conference Call Final Transcript
COVID-19: Significant Shift in Strategy of Orthopedic Implants Market 2020-2024 | Rising Prevalence of Orthopedic Conditions to Augment Growth | Technavio 2020/06/25 23:50:00 Benzinga Feeds
Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005787/en/ Technavio has announced its latest market research report titled Global Orthopedic Implants Market 2020-2024 (Graphic: Business Wire). Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.